Stories about effectiveness
-
Language:
English
- Media:
- Period:
- Period:Total
- more
ETNA-AF-Europe Registry Data on LIXIANA®(edoxaban) Published in a Leading Cardiology Journal Highlights Important Clinical Considerations for Treating Ageing Patients with Atrial Fibrillation
moreTechnische Universität München
Meta-study: Successful school instruction is digital - but not exclusively
moreTechnische Universität München
Grow faster, die sooner: How growth rates influence the fitness of bacteria
morePriority Software Showcases Ease of Use, Increased Process Efficiency and Cost Effectiveness at Leading UK Retail Manufacturer, Trutex
moreZhejiang Hisun Pharmaceutical Co. Ltd.
Favipiravir works! Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients
moreNew in-vivo study confirms that ciliate vaccine protects against flu
moreEuropean Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA® (edoxaban)
moreJTI Japan Tobacco International AG
72% Say Policy-Making Should Be Open to Dialogue With Business: New European Research Commissioned by JTI Shows that Policies Based on Evidence and Dialogue Are Needed to Restore Public Trust in Policy-Making
moreThe Thrombosis Research Institute
Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018
more
1